Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice
about
MECP2 disorders: from the clinic to mice and backDendritic spine dysgenesis in autism related disordersBDNF deregulation in Rett syndromeSynaptic maturation at cortical projections to the lateral amygdala in a mouse model of Rett syndromeDeveloping and applying the adverse outcome pathway concept for understanding and predicting neurotoxicityBdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutationsA BDNF loop-domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome.Preclinical research in Rett syndrome: setting the foundation for translational success.Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in an RNA interference model of methyl-CpG-binding protein 2 deficiency.Effect of Sarizotan, a 5-HT1a and D2-like receptor agonist, on respiration in three mouse models of Rett syndromeExperimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin DamageMeCP2 is required for normal development of GABAergic circuits in the thalamus.Is X-linked methyl-CpG binding protein 2 a new target for the treatment of Parkinson's diseaseDendritic spine dysgenesis in Rett syndrome.Neuronal activity-regulated gene transcription in synapse development and cognitive function.7,8-dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndromeA selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome.Acetyl-L-carnitine improves behavior and dendritic morphology in a mouse model of Rett syndrome.Setdb1-mediated histone H3K9 hypermethylation in neurons worsens the neurological phenotype of Mecp2-deficient mice.Experimental models of Rett syndrome based on Mecp2 dysfunction.Synaptic determinants of rett syndrome.MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons.Abnormal expression of cerebrospinal fluid cation chloride cotransporters in patients with Rett syndromeBrain-derived neurotrophic factor inhibits calcium channel activation, exocytosis, and endocytosis at a central nerve terminal.The disruption of central CO2 chemosensitivity in a mouse model of Rett syndrome.Synaptic microcircuit dysfunction in genetic models of neurodevelopmental disorders: focus on Mecp2 and Met.Acute intermittent hypoxia-induced expression of brain-derived neurotrophic factor is disrupted in the brainstem of methyl-CpG-binding protein 2 null mice.Impaired CO2 sensitivity of astrocytes in a mouse model of Rett syndrome.MicroRNAs downregulated in neuropathic pain regulate MeCP2 and BDNF related to pain sensitivity.Dynamic regulation of estrogen receptor-alpha gene expression in the brain: a role for promoter methylation?Advances in behavioral genetics: mouse models of autism.A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndromeRett syndrome: recent research progress.BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation.Brain-derived neurotrophic factor enhances fetal respiratory rhythm frequency in the mouse preBötzinger complex in vitro.Breathing dysfunction in Rett syndrome: understanding epigenetic regulation of the respiratory networkEvaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.Activity-dependent thalamocortical axon branching.Breathing challenges in Rett syndrome: lessons learned from humans and animal models.Enhanced dense core granule function and adrenal hypersecretion in a mouse model of Rett syndrome.
P2860
Q26799760-ADFFF393-6472-410E-BCA5-CD02FC7402DEQ26995242-C2765AE2-2CE4-47EC-A3EC-1AB7D46692FBQ27005901-D291F72B-2C06-4005-8972-243F475E3930Q27324376-557DA73B-4B27-4F42-986C-F73E059F5252Q28394433-ACE6F5BB-C821-45ED-A716-0EC8068090F2Q28941188-E308C2E5-E002-467F-859E-DB15856D9A45Q30431760-DAEDFFC9-5BA2-4C9D-8012-3BBF73ED7859Q30527828-0010706B-9C79-48C8-B8F3-C21971E777B4Q33509272-AFEC66C5-F5C5-4EB1-97BF-483EBD5F3840Q33799538-D5D8739E-967F-4197-826D-EECCFA39007BQ33838894-5418E299-E95E-4D30-8AF1-A3AA1430BC21Q33841359-4459975C-6939-4E73-9DA7-2B20C9FE85B5Q34094521-CC0B6C66-0E21-41E0-873F-BA6B36F16D6CQ34159085-5F66BB6D-396D-44F4-8B98-A5E85A6BFC35Q34183712-70D3E0FA-AECF-46FC-BFA9-B30F8991B457Q34242515-07231203-20E8-4260-A823-68582E955803Q34410663-7C6BB923-C694-49FF-A299-04518AA516B8Q34507396-7916C539-9B6A-4F84-9D39-F523056BC627Q34511024-0994C0D0-2A5E-4760-AFEB-4A0496E5D81DQ34686591-0B7B0CC8-E42B-449F-BBDB-4C5860BAA1B6Q34689838-7B5AD183-F262-48D8-96A6-FA79E993ECC2Q34764182-3A4BB36D-A840-40ED-BDD1-7489DDD6E6CBQ34873355-1895591F-95E0-4DBB-9E0F-C3588D344FDCQ35187479-7FF93DEE-C9E4-4191-B3F5-DA386FADF24AQ35216828-988D7896-5FF1-41C2-8E43-9AE3D4D4957EQ35417476-F3224AA3-97F8-42F8-A6A3-B4B4FFB60C8BQ35802970-78F60B17-58C9-44E4-94AB-BE3CDBA71225Q35940510-DF55DA36-B98D-447B-A75C-F6E22A1175F9Q36064254-9FB97373-A305-422A-BB7D-9A172F665FE0Q36762940-EFB18CE3-DD87-403D-96D0-FD12300A6ABCQ36937876-FDF195CC-DC5F-4901-89C4-CA47E4231AB0Q37008339-F8BD7FA3-D682-4E18-8D71-ECCA71B8A9C2Q37023198-F1021F3C-47B6-4D71-A42B-4A38A21F5B6DQ37061555-E6518CD9-02CC-40E8-AAC7-0FA33D875AB3Q37148668-5FC1A481-520F-4514-A6E8-57861B1F7209Q37148672-7A19696C-3ADA-4F11-B7B1-1434296671ACQ37213531-B9098370-1C2E-4E28-B792-35C92ACDDF9AQ37228042-1CA95838-0982-4B59-8726-2AB4869D1CEBQ37265909-4CDAE380-F4CA-4BE6-B5C4-A5E46DA99C8BQ37379867-C030968A-2822-4C29-8E0B-38A9EC7E7179
P2860
Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice
description
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Oktober 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/10/18)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/10/18)
@nl
наукова стаття, опублікована в жовтні 2006
@uk
مقالة علمية نشرت في 18-10-2006 حول موضوع: دماغ
@ar
name
Dysregulation of brain-derived ...... ry function in Mecp2 null mice
@ast
Dysregulation of brain-derived ...... ry function in Mecp2 null mice
@en
Dysregulation of brain-derived ...... ry function in Mecp2 null mice
@nl
type
label
Dysregulation of brain-derived ...... ry function in Mecp2 null mice
@ast
Dysregulation of brain-derived ...... ry function in Mecp2 null mice
@en
Dysregulation of brain-derived ...... ry function in Mecp2 null mice
@nl
prefLabel
Dysregulation of brain-derived ...... ry function in Mecp2 null mice
@ast
Dysregulation of brain-derived ...... ry function in Mecp2 null mice
@en
Dysregulation of brain-derived ...... ry function in Mecp2 null mice
@nl
P2093
P3181
P1476
Dysregulation of brain-derived ...... ry function in Mecp2 null mice
@en
P2093
Corey Smith
David Hellard
David M Katz
Michael Ogier
Qifang Wang
Shyue-an Chan
P304
10911-10915
P3181
P356
10.1523/JNEUROSCI.1810-06.2006
P407
P577
2006-10-18T00:00:00Z